Clinical Trial

BRIDGE-US: Bridging Readiness in Deployed Neurotrauma Gaps for Excellence

Study acronym: BRIDGE-US
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to prospectively collect biospecimens, imaging, and clinical data from patients with penetrating brain injuries across high-volume PBI sites in the US (including UChicago). Biospecimens will undergo biomarker analysis - biomarker data specific to PBI is extremely limited, and could provide critical insight to outcome identification and clinical decision making. This data will be used to build the first comprehensive PBI Data Commons, biorepository, and imaging repository which will create the infrastructure necessary to close critical knowledge gaps, advance biomarker discovery specific to PBI, and provide the foundation for future research aimed at improving prognostication and treatment for patients with this devastating injury.
Trial Details
NCT Number NCT07636213
Lead Sponsor University of Chicago
Conditions Brain Injuries, Acute, Brain Trauma, Penetrating Head Injury, Traumatic Brain Injury
Enrollment 270 participants
Start Date 2026-07-01
Primary Completion 2035-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-09